Norimichi Tomohiro
-
- Traditional Chinese Medicine Analysis 5
- Mangiferin and Mango Extracts 2
- Pharmacology top 5%
- Fungal Biology and Applications 3
- Berberine and alkaloids research 2
- Pharmacology and Obesity Treatment 2
-
- Phytochemicals and Antioxidant Activities 3
-
- Natural product bioactivities and synthesis 4
-
- Essential Oils and Antimicrobial Activity 3
- Co-authors
- Hideaki MatsudaMichinori KuboMasayuki YoshikawaMasayuki YOSHIKAWAMichinori KUBOShoichi HarimaKeizo MatsuoMegumi Masuda
- Journals
- Biological and Pharmaceutical Bulletin (5 papers)Chemical and Pharmaceutical Bulletin (1 paper)Natural Product Communications (1 paper)
- Partner nations
- Japan
In The Last Decade
Norimichi Tomohiro
14 papers receiving 386 citations
Peers
Comparison fields: 5 of 69
- Complementary and alternative medicine 91
- Pharmacology 89
- Geriatrics and Gerontology 24
- Biochemistry 28
- Immunology and Allergy 24
Countries citing papers authored by Norimichi Tomohiro
This map shows the geographic impact of Norimichi Tomohiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norimichi Tomohiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norimichi Tomohiro more than expected).
Fields of papers citing papers by Norimichi Tomohiro
This network shows the impact of papers produced by Norimichi Tomohiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norimichi Tomohiro. The network helps show where Norimichi Tomohiro may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Norimichi Tomohiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 3 | |
| 2 | 2020 | 1 | |
| 3 | 2020 | 14 | |
| 4 | 2019 | 8 | |
| 5 | 2008 | 37 | |
| 6 | [Historical and pharmalogical study of Citrus hassaku.]. | 2005 | 6 |
| 7 | [History and therapeutic evaluation of Citrus hassaku HORT. Tanaka]. | 2004 | 1 |
| 8 | 2002 | 131 | |
| 9 | 2001 | 66 | |
| 10 | 1999 | 8 | |
| 11 | 1999 | 27 | |
| 12 | Stereostructures of New Protostane-Type Triterpenes, Alisols H, I, J-23-Acetate, K-23-Acetate, L-23-Acetate, M-23-Acetate, and N-23-Acetate, from the Dried Rhizome of Alisma orientale | 1999 | 2 |
| 13 | 1998 | 42 | |
| 14 | 1997 | 61 |
About Norimichi Tomohiro
Norimichi Tomohiro is a scholar working on Complementary and alternative medicine, Biochemistry and Pharmacology, having authored 14 papers that have together received 407 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (5 papers), Natural product bioactivities and synthesis (4 papers), Essential Oils and Antimicrobial Activity (3 papers), Phytochemicals and Antioxidant Activities (3 papers), Fungal Biology and Applications (3 papers), Berberine and alkaloids research (2 papers), Pharmacology and Obesity Treatment (2 papers) and Mangiferin and Mango Extracts (2 papers). The work is most often cited by research in Complementary and alternative medicine (91 citations), Pharmacology (89 citations) and Geriatrics and Gerontology (24 citations). Norimichi Tomohiro has collaborated with scholars based in Japan. Frequent co-authors include Hideaki Matsuda, Michinori Kubo, Masayuki Yoshikawa, Masayuki YOSHIKAWA, Michinori KUBO, Shoichi Harima, Keizo Matsuo, Megumi Masuda, Tadashi Fujita and Atsushi Kawase. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Chemical and Pharmaceutical Bulletin and Natural Product Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.